A prospective trial of CT-guided percutaneous microwave ablation for lung tumors

Percutaneous ablation is an alternative treatment for lung cancer in non-operable patients. This is a prospective clinical trial for percutaneous microwave ablation (pMWA) of biopsy-proven lung cancer to demonstrate safety and efficacy. A prospective trial from 6-1-2016 to 1-1-2019 enrolled patients...

Full description

Saved in:
Bibliographic Details
Published in:Journal of thoracic disease 2022-04, Vol.14 (4), p.939-951
Main Authors: Reisenauer, Janani S, Eiken, Patrick W, Callstrom, Matthew R, Johnson, Geoffrey B, Pierson, Karlyn, Lechtenberg, Bettie, Blackmon, Shanda H
Format: Article
Language:English
Subjects:
Original
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Percutaneous ablation is an alternative treatment for lung cancer in non-operable patients. This is a prospective clinical trial for percutaneous microwave ablation (pMWA) of biopsy-proven lung cancer to demonstrate safety and efficacy. A prospective trial from 6-1-2016 to 1-1-2019 enrolled patients with biopsy-proven primary or metastatic lung cancer
ISSN:2072-1439
2077-6624
DOI:10.21037/jtd-21-1636